Topic Editors

Department of Psychology, Fo Guang University, Yilan County 26247, Taiwan
Institute of Biomedical Sciences, Academia Sinica, Taipei 1529, Taiwan
Department of Bionanotechnology, Gachon Medical Research Institute, Gachon University, Seongnam 13120, Republic of Korea
Department of Human Physiology and Pathology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska Av 30, 10-082 Olsztyn, Poland

Applications of Immunohistochemical Staining in Brain Diseases

Abstract submission deadline
closed (30 September 2024)
Manuscript submission deadline
31 December 2024
Viewed by
4546

Topic Information

Dear Colleagues,

Immunohistochemical staining (IHC) can be used to qualitatively or quantitatively recognize analytes involving peptides, proteins, or small molecules. The IHC technique can link to molecular imaging, bioinformatics analysis, artificial intelligence (AI)-based methods, therapeutic targeting with brain therapy, and basic research in brain diseases. Advances in IHC-related applications enable early detection and precise treatment in disease management. This Topic aims to apply cutting-edge research into multidisciplinary frontier viewpoints to various novelty concerns and provide insights into clinical issues underlying recent advances in aspects of disease treatment. Authors are invited to submit both reviews and original articles to our Topic collection. Potential subject include, but are not limited to:

  1. Biomarkers or risk factors involving neuroinflammation or mitochondrial function in cell-to-animal innovative research of disease;
  2. Diagnostic strategies targeting various brain diseases;
  3. Molecular imaging that can reflect or predict disease development;
  4. Bench-to-bedside applications to disease diagnosis, treatment, and clinical outcome, including IHC-based molecular or pharmacological interventions;
  5. Biocybernetics and big data processing of large databases and genomics interactions using bioinformatics approaches;
  6. Label the biomarkers for targeting brain diseases.

Prof. Dr. Andrew Chih Wei Huang
Dr. Bai Chuang Shyu
Prof. Dr. Seong Soo A. An
Dr. Anna Kozłowska
Topic Editors

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Brain Sciences
brainsci
2.7 4.8 2011 12.9 Days CHF 2200 Submit
Cells
cells
5.1 9.9 2012 17.5 Days CHF 2700 Submit
Diagnostics
diagnostics
3.0 4.7 2011 20.5 Days CHF 2600 Submit
International Journal of Molecular Sciences
ijms
4.9 8.1 2000 18.1 Days CHF 2900 Submit
Journal of Personalized Medicine
jpm
3.0 4.1 2011 16.7 Days CHF 2600 Submit

Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (2 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
21 pages, 7276 KiB  
Article
The P2X7 Hypothesis of Central Post-Stroke Pain
by Andrew Chih Wei Huang, Hsi-Chien Shih and Bai Chuang Shyu
Int. J. Mol. Sci. 2024, 25(12), 6577; https://doi.org/10.3390/ijms25126577 - 14 Jun 2024
Viewed by 677
Abstract
The present study examined how P2X7 receptor knockout (KO) modulates central post-stroke pain (CPSP) induced by lesions of the ventrobasal complex (VBC) of the thalamus in behaviors, molecular levels, and electrical recording tests. Following the experimental procedure, the wild-type and P2X7 receptor KO [...] Read more.
The present study examined how P2X7 receptor knockout (KO) modulates central post-stroke pain (CPSP) induced by lesions of the ventrobasal complex (VBC) of the thalamus in behaviors, molecular levels, and electrical recording tests. Following the experimental procedure, the wild-type and P2X7 receptor KO mice were injected with 10 mU/0.2 μL type IV collagenase in the VBC of the thalamus to induce an animal model of stroke-like thalamic hemorrhage. Behavioral data showed that the CPSP group induced thermal and mechanical pain. The P2X7 receptor KO group showed reduced thermal and mechanical pain responses compared to the CPSP group. Molecular assessments revealed that the CPSP group had lower expression of NeuN and KCC2 and higher expression of GFAP, IBA1, and BDNF. The P2X7 KO group showed lower expression of GFAP, IBA1, and BDNF but nonsignificant differences in KCC2 expression than the CPSP group. The expression of NKCC1, GABAa receptor, and TrkB did not differ significantly between the control, CPSP, and P2X7 receptor KO groups. Muscimol, a GABAa agonist, application increased multiunit numbers for monitoring many neurons and [Cl] outflux in the cytosol in the CPSP group, while P2X7 receptor KO reduced multiunit activity and increased [Cl] influx compared to the CPSP group. P2X4 receptor expression was significantly decreased in the 100 kDa but not the 50 kDa site in the P2X7 receptor KO group. Altogether, the P2X7 hypothesis of CPSP was proposed, wherein P2X7 receptor KO altered the CPSP pain responses, numbers of astrocytes and microglia, CSD amplitude of the anterior cingulate cortex and the medial dorsal thalamus, BDNF expression, [Cl] influx, and P2X4 expression in 100 kDa with P2X7 receptors. The present findings have implications for the clinical treatment of CPSP symptoms. Full article
Show Figures

Figure 1

12 pages, 3877 KiB  
Article
A Scalable Histological Method to Embed and Section Multiple Brains Simultaneously
by Divine C. Nwafor, Stanley A. Benkovic, Briana L. Clary, Allison L. Brichacek, H. Wayne Lambert, Matthew J. Zdilla and Candice M. Brown
Cells 2024, 13(10), 860; https://doi.org/10.3390/cells13100860 - 17 May 2024
Viewed by 3139
Abstract
The preparation and processing of rodent brains for evaluation by immunohistochemistry is time-consuming. A large number of mouse brains are routinely used in experiments in neuroscience laboratories to evaluate several models of human diseases. Thus, methods are needed to reduce the time associated [...] Read more.
The preparation and processing of rodent brains for evaluation by immunohistochemistry is time-consuming. A large number of mouse brains are routinely used in experiments in neuroscience laboratories to evaluate several models of human diseases. Thus, methods are needed to reduce the time associated with processing brains for histology. A scalable method was developed to embed, section, and stain multiple mouse brains using supplies found in any common histology laboratory. Section collection schemes can be scaled to provide identical bregma locations between adjacent sections for immunohistochemistry, facilitating comprehensive, high-quality immunohistochemistry. As a result, sectioning and staining times are considerably reduced as sections from multiple blocks are stained simultaneously. This method improves on previous procedures and allows multiple embedding and subsequent immunostaining of brains easily with a dramatically reduced time requirement. Furthermore, we expand this method for use in numerous mouse tissues, rat brain tissue, and post-mortem human brain and arterial tissues. In summary, this procedure allows the processing of many rodent or human tissues from perfusion through microscopy in 10 days or less. Full article
Show Figures

Figure 1

Back to TopTop